首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1900327

禽流感疫苗市场规模、份额和成长分析（按疫苗类型、应用、病毒株、给药途径、目标类型、通路和地区划分）－2026-2033年产业预测

Avian Influenza Vaccine Market Size, Share, and Growth Analysis, By Vaccine Type, By Application, By Strain, By Administration Route, By Target Species, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 215 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球禽流感疫苗市场规模将达到 1,520.1 亿美元，到 2025 年将达到 1,583.9 亿美元，到 2033 年将达到 2,201.3 亿美元，预测期（2026-2033 年）的复合年增长率为 4.2%。

全球禽流感疫苗市场洞察显示，人们对主要感染家禽、起源于水禽的甲型禽流感病毒高度关注。目前已出现多种亚型，包括H5N1、H7N3、H7N9和H9N2，其中H5N1被认为是致病性最强的。潜在的人类感染凸显了研发有效疫苗的迫切性。禽流感疫苗依株分为H5、H7和H9疫苗。中国已成为领先的疫苗生产国，其次是美国。随着全球对禽流感的认识不断提高，针对特定株的疫苗需求预计将会成长，从而推动疫苗研发领域的进一步投资和创新，以降低相关的健康风险。

全球禽流感疫苗市场驱动因素

全球禽流感疫苗市场的主要驱动力是禽流感病毒（尤其是甲型禽流感病毒）的传播和影响。甲型禽流感病毒在水禽中很流行，但也会感染鸡隻和其他家禽。根据其表面蛋白（血凝素和神经氨酸酶）的不同，禽流感病毒可分为多种亚型，并根据致病性分为高致病性和低致病性。非致病性变异株可能引起轻微症状，而高致病性株则会导致家禽高死亡率，因此，有效的疫苗接种策略对于保护禽群和减少家禽业的经济损失至关重要。

限制全球禽流感疫苗市场的因素

全球禽流感疫苗市场面临的主要挑战在于禽流感病毒的快速变异。这些变异阻碍了有效疫苗接种覆盖率的维持。病毒的不断进化需要持续的研究来更好地了解其动态，从而为改进疫苗配方铺平道路。由于需要不断创新和投资才能确保疫苗接种工作在对抗不断变化的病原体方面保持相关性和有效性，因此，疫苗需要根据这些变异进行调整，这构成了市场限制。

全球禽流感疫苗市场趋势

全球禽流感疫苗市场呈现显着上升趋势，尤其是在亚太地区。这主要是由于禽流感病毒在以色列、中国、印度和韩国等主要国家的蔓延。供应链效率的提升加快了疫苗供应速度，而强大的研发基础以及政府的支持政策则加速了疫苗技术的创新。人们对禽流感经济和健康影响的认识不断提高，进一步推动了对有效疫苗解决方案的需求。因此，相关人员正积极投资于先进疫苗的研发，以期在这个重要市场中占据成长优势。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Sanofi（France）
GlaxoSmithKline（GSK）（United Kingdom）
Moderna Inc.（United States）
Pfizer Inc.（United States）
AstraZeneca（United Kingdom）
Novavax, Inc.（United States）
Vaxart, Inc.（United States）
BioNTech SE（Germany）
Sinovac Biotech Ltd.（China）
Bharat Biotech International Ltd.（India）
Serum Institute of India Pvt. Ltd.（India）
Daiichi Sankyo Company, Limited（Japan）
Mitsubishi Tanabe Pharma Corporation（Japan）
Seqirus UK Limited（United Kingdom）
Emergent BioSolutions Inc.（United States）
Johnson & Johnson（United States）
Abbott Laboratories（United States）
Roche Holding AG（Switzerland）
Merck & Co., Inc.（United States）

结论与建议

简介目录

Product Code: SQMIG35A2886

Global Avian Influenza Vaccine Market size was valued at USD 152.01 Billion in 2024 and is poised to grow from USD 158.39 Billion in 2025 to USD 220.13 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

Global insights into the avian influenza vaccine market reveal significant concerns surrounding the avian influenza virus type A, primarily affecting domestic poultry and originating from waterfowl. Notably, various subtypes such as H5N1, H7N3, H7N9, and H9N2 have emerged, with H5N1 recognized as the most pathogenic. The transmission potential to humans highlights the urgency of effective vaccine development. The avian influenza vaccine classification includes H5, H7, and H9 vaccines, catering to different strains. China has established itself as a major manufacturer, while the U.S. follows closely. As global awareness of avian influenza grows, the demand for vaccines targeting these specific strains is anticipated to rise, promoting further investment and innovation in vaccine development to mitigate associated health risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Avian Influenza Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Avian Influenza Vaccine Market Segments Analysis

Global Avian Influenza Vaccine Market is segmented by Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines, Recombinant Vaccines and Subunit Vaccines. Based on Application, the market is segmented into Chicken, Duck and Goose, Turkey and Others. Based on Strain, the market is segmented into H5 Strain, H7 Strain and H9 Strain. Based on Administration Route, the market is segmented into Intramuscular, Subcutaneous and Waterborne. Based on Target Species, the market is segmented into Broilers, Layers, Breeders and Backyard Poultry. Based on Distribution Channel, the market is segmented into Veterinary Clinics, Online Pharmacies and Retail Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Avian Influenza Vaccine Market

The global market for avian influenza vaccines is primarily driven by the prevalence and impact of the avian influenza virus, particularly type A, which is frequently found in waterfowl and can infect domestic poultry like chickens. This virus is categorized into various subtypes based on its surface proteins, namely hemagglutinin and neuraminidase, which play a role in its classification as either highly pathogenic or low pathogenic. While nonpathogenic variants may lead to mild symptoms, highly pathogenic strains can result in significant mortality rates in poultry, necessitating effective vaccination strategies to protect bird populations and mitigate economic losses in the poultry industry.

Restraints in the Global Avian Influenza Vaccine Market

A significant challenge in the Global Avian Influenza Vaccine market arises from the swift mutation rate of the avian influenza virus, which hampers efforts to sustain effective vaccine coverage. This constant evolution of the virus necessitates ongoing research to gain a deeper understanding of its dynamics, paving the way for enhancements in vaccine formulations. The need to adapt vaccines to address these mutations poses a restraint on the market, as it demands continuous innovation and investment to ensure that immunization efforts remain relevant and effective in combating this ever-changing pathogen.

Market Trends of the Global Avian Influenza Vaccine Market

The Global Avian Influenza Vaccine market is witnessing a significant upward trend, particularly in the Asia-Pacific region, driven by the prevalence of bird flu viruses in key countries such as Israel, China, India, and South Korea. Enhanced supply chain efficiencies facilitate faster vaccine distribution, while robust research and development infrastructures, supported by favorable government policies, are accelerating innovation in vaccine technology. Increased awareness about the economic and health impacts of avian influenza is further propelling demand for effective vaccination solutions. As a result, stakeholders are actively investing in advanced vaccine developments, positioning themselves for growth in this critical market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Avian Influenza Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

Market Overview
Inactivated Vaccines
Live Recombinant Vaccines
Combination Vaccines
Recombinant Vaccines
Subunit Vaccines

Global Avian Influenza Vaccine Market Size by Application & CAGR (2026-2033)

Market Overview
Chicken
Duck and Goose
Turkey
Others

Global Avian Influenza Vaccine Market Size by Strain & CAGR (2026-2033)

Market Overview
H5 Strain
H7 Strain
H9 Strain

Global Avian Influenza Vaccine Market Size by Administration Route & CAGR (2026-2033)

Market Overview
Intramuscular
Subcutaneous
Waterborne

Global Avian Influenza Vaccine Market Size by Target Species & CAGR (2026-2033)

Market Overview
Broilers
Layers
Breeders
Backyard Poultry

Global Avian Influenza Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Veterinary Clinics
Online Pharmacies
Retail Stores

Global Avian Influenza Vaccine Market Size & CAGR (2026-2033)

North America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- US
- Canada
Europe (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxart, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioNTech SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinovac Biotech Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech International Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seqirus UK Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent BioSolutions Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Conclusion & Recommendations

02-2729-4219

+886-2-2729-4219

License/价格

禽流感疫苗市场规模、份额和成长分析（按疫苗类型、应用、病毒株、给药途径、目标类型、通路和地区划分）－2026-2033年产业预测

Avian Influenza Vaccine Market Size, Share, and Growth Analysis, By Vaccine Type, By Application, By Strain, By Administration Route, By Target Species, By Distribution Channel, By Region - Industry Forecast 2026-2033

目录

介绍

调查方法

执行摘要

市场动态与展望

关键市场考察

全球禽流感疫苗市场规模（依疫苗类型及复合年增长率划分）（2026-2033 年）

全球禽流感疫苗市场规模（按应用及复合年增长率划分）（2026-2033 年）

全球禽流感疫苗市场规模（依病毒株划分）及复合年增长率（2026-2033 年）

全球禽流感疫苗市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

全球禽流感疫苗市场规模（按类型及复合年增长率划分）（2026-2033 年）

全球禽流感疫苗市场规模（依通路划分）及复合年增长率（2026-2033 年）

全球禽流感疫苗市场规模（按地区划分）及复合年增长率（2026-2033 年）